12/19/2011 – “Agenus and ChemRar Enter Into Agreement in the Area of Personalized Cancer Vaccines” press release
12/12/2011 – “Updated Results From Cyclacel Clinical Study Highlight Safety and Efficacy of Sequential Administration of Sapacitabine and Decitabine in Elderly Patients With AML” press release
11/15/2011 – “Bavarian Nordic Initiates Pivotal Phase 3 Trial of PROSTVAC® Prostate Cancer Immunotherapy” press release
10/18/2011 – “Positive Results Shown With Agenus’ QS-21 Stimulon(R) Adjuvant in Phase 3 Trial of GlaxoSmithKline’s Malaria Vaccine” press release
9/26/2011 – “Clinical Data Published in Vaccine Demonstrate Robust Immune Response With Agenus’ Herpes Vaccine Containing QS-21 Adjuvant” press release
8/18/2011 – “Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program” press release
